Neural crest cells: From developmental biology to clinical interventions

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 102, Issue 3, 2014, Pages 263-274

  Noisa, Parinya ^a,b   Raivio, Taneli ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Human pluripotent stem cells; Neural crest cells; Neurocristopathies

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DEVELOPMENTAL BIOLOGY; DISEASE MODEL; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MULTIPOTENT STEM CELL; NEURAL CREST; PHYSIOLOGY; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; DEVELOPMENTAL BIOLOGY; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MULTIPOTENT STEM CELLS; NEURAL CREST; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84908501098     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21074     Document Type: Article

References (110)

1. Aaku-Saraste E, Hellwig A, Huttner WB. 1996. Loss of occludin and functional tight junctions, but not ZO-1, during neural tube closure-remodeling of the neuroepithelium prior to neurogenesis. Dev Biol 180:664-679.
2. Aybar MJ, Nieto MA, Mayor R. 2003. Snail precedes slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development 130:483-494.
3. Bagheri-Fam S, Barrionuevo F, Dohrmann U, et al. 2006. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern. Dev Biol 291:382-397.
4. Bajpai R, Chen DA, Rada-Iglesias A, et al. 2010. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463:958-962.
5. Barraud P, St John JA, Stolt CC, et al. 2013. Olfactory ensheathing glia are required for embryonic olfactory axon targeting and the migration of gonadotropin-releasing hormone neurons. Biol Open 2:750-759.
6. Basch ML, Bronner-Fraser M, Garcia-Castro MI. 2006. Specification of the neural crest occurs during gastrulation and requires Pax7. Nature 441:218-222.
7. Bolande RP. 1974. Congenital and infantile neoplasia of the kidney. Lancet 7895:1497-1499.
8. Bondurand N, Dastot-Le Moal F, Stanchina L, et al. 2007. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet 81:1169-1185.
9. Britsch S, Goerich DE, Riethmacher D, et al. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15:66-78.
10. Bronner-Fraser M. 1995. Origins and developmental potential of the neural crest. Exp Cell Res 218:405-417.
11. Campuzano V, Montermini L, Molto MD, et al. 1996. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427.
12. Cartwright MM, Smith SM. 1995. Stage-dependent effects of ethanol on cranial neural crest cell development: partial basis for the phenotypic variations observed in fetal alcohol syndrome. Alcohol Clin Exp Res 19:1454-1462.
13. Cheng X, Blumenthal RM. 2008. Mammalian DNA methyltransferases: a structural perspective. Structure 16:341-350.
14. Cheung M, Briscoe J. 2003. Neural crest development is regulated by the transcription factor Sox9. Development 130:5681-5693.
15. Close P, Hawkes N, Cornez I, et al. 2006. Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell 22:521-531.
16. Cornell RA, Eisen JS. 2002. Delta/Notch signaling promotes formation of zebrafish neural crest by repressing Neurogenin 1 function. Development 129:2639-2648.
17. Corti S, Nizzardo M, Simone C, et al. 2012. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med 4:165ra162.
18. Costa-Barbosa FA, Balasubramanian R, Keefe KW, et al. 2013. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab 98:E943-953.
19. Curchoe CL, Maurer J, McKeown SJ, et al. 2010. Early acquisition of neural crest competence during hESCs neuralization. PloS one 5:e13890.
20. Cyranoski D. 2013. Stem cells cruise to clinic. Nature 494:413.
21. De Bellard ME, Ching W, Gossler A, et al. 2002. Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. Dev Biol 249:121-130.
22. de Croze N, Maczkowiak F, Monsoro-Burq AH. 2011. Reiterative AP2a activity controls sequential steps in the neural crest gene regulatory network. Proc Natl Acad Sci USA 108:155-160.
23. Dottori M, Gross MK, Labosky P, et al. 2001. The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate. Development 128:4127-4138.
24. Durchfort N, Verhoef S, Vaughn MB, et al. 2012. The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion. Traffic 13:108-119.
25. Durruthy-Durruthy J, Briggs SF, Awe J, et al. 2014. Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions. PloS one 9:e94231.
26. Dutton KA, Pauliny A, Lopes SS, et al. 2001. Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates. Development 128:4113-4125.
27. Eigentler A, Boesch S, Schneider R, et al. 2013. Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons. Stem Cells Dev 22:3271-3282.
28. Endo Y, Ishiwata-Endo H, Yamada KM. 2012. Extracellular matrix protein anosmin promotes neural crest formation and regulates FGF, BMP, and WNT activities. Dev Cell 23:305-316.
29. Endo Y, Osumi N, Wakamatsu Y. 2002. Bimodal functions of Notch-mediated signaling are involved in neural crest formation during avian ectoderm development. Development 129:863-873.
30. Fernandez-Garre P, Rodriguez-Gallardo L, Gallego-Diaz V, et al. 2002. Fate map of the chicken neural plate at stage 4. Development 129:2807-2822.
31. Fong H, Wang C, Knoferle J, et al. 2013. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep 1:226-234.
32. Franco B, Guioli S, Pragliola A, et al. 1991. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529-536.
33. Hay DC, Zhao D, Fletcher J, et al. 2008. Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 26:894-902.
34. High FA, Zhang M, Proweller A, et al. 2007. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 117:353-363.
35. Hong CS, Park BY, Saint-Jeannet JP. 2008. Fgf8a induces neural crest indirectly through the activation of Wnt8 in the paraxial mesoderm. Development 135:3903-3910.
36. Honore SM, Aybar MJ, Mayor R. 2003. Sox10 is required for the early development of the prospective neural crest in Xenopus embryos. Dev Biol 260:79-96.
37. Hou P, Li Y, Zhang X, et al. 2013. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651-654.
38. Hu N, Strobl-Mazzulla P, Sauka-Spengler T, et al. 2012. DNA methyltransferase3A as a molecular switch mediating the neural tube-to-neural crest fate transition. Genes Dev 26:2380-2385.
39. Ikeya M, Lee SM, Johnson JE, et al. 1997. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 389:966-970.
40. Inoue K, Shilo K, Boerkoel CF, et al. 2002. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann Neurol 52:836-842.
41. Introne W, Boissy RE, Gahl WA. 1999. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 68:283-303.
42. Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. 2000. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6:88-95.
43. Jacob C, Lotscher P, Engler S, et al. 2014. HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia. J Neurosci 34:6112-6122.
44. Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, et al. 2009. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. Clin Genet 75:65-71.
45. Kassar-Duchossoy L, Giacone E, Gayraud-Morel B, et al. 2005. Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev 19:1426-1431.
46. Kim D, Kim CH, Moon JI, et al. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476.
47. Kim HG, Kurth I, Lan F, et al. 2008. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 83:511-519.
48. Kos R, Reedy MV, Johnson RL, et al. 2001. The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development 128:1467-1479.
49. Kulesa PM, Bailey CM, Kasemeier-Kulesa JC, et al. 2010. Cranial neural crest migration: new rules for an old road. Dev Biol 344:543-554.
50. Le Douarin NM, Calloni GW, Dupin E. 2008. The stem cells of the neural crest. Cell Cycle 7:1013-1019.
51. Le Douarin NM, Dupin E. 2003. Multipotentiality of the neural crest. Curr Opin Genet Dev 13:529-536.
52. Lee G, Kim H, Elkabetz Y, et al. 2007. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 25:1468-1475.
53. Lee G, Papapetrou EP, Kim H, et al. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461:402-406.
54. Lee G, Ramirez CN, Kim H, et al. 2012. Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol 30:1244-1248.
55. Legouis R, Hardelin JP, Levilliers J, et al. 1991. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423-435.
56. Lensch MW, Schlaeger TM, Zon LI, et al. 2007. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 1:253-258.
57. Li W, Xiong Y, Shang C, et al. 2013. Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development. Proc Natl Acad Sci USA 110:1738-1743.
58. Li Z, Dullmann J, Schiedlmeier B, et al. 2002. Murine leukemia induced by retroviral gene marking. Science 296:497.
59. Liu J, Verma PJ, Evans-Galea MV, et al. 2011. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev 7:703-713.
60. Mansouri A, Stoykova A, Torres M, et al. 1996. Dysgenesis of cephalic neural crest derivatives in Pax7-/- mutant mice. Development 122:831-838.
61. Marchant L, Linker C, Ruiz P, et al. 1998. The inductive properties of mesoderm suggest that the neural crest cells are specified by a BMP gradient. Dev Biol 198:319-329.
62. Martinez-Morales PL, Diez del Corral R, Olivera-Martinez I, et al. 2011. FGF and retinoic acid activity gradients control the timing of neural crest cell emigration in the trunk. J Cell Biol 194:489-503.
63. Martucciello G, Lerone M, Bricco L, Tonini GP, Lombardi L, Del Rossi CG, Bernasconi S. 2012. Multiple endocrine neoplasias type 2B and RET proto-oncogene. Ital J Pediatr 38:9.
64. Mayor R, Morgan R, Sargent MG. 1995. Induction of the prospective neural crest of Xenopus. Development 121:767-777.
65. Mead TJ, Yutzey KE. 2012. Notch pathway regulation of neural crest cell development in vivo. Dev Dyn 241:376-389.
66. Menendez L, Yatskievych TA, Antin PB, et al. 2011. Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci USA 108:19240-19245.
67. Mica Y, Lee G, Chambers SM, et al. 2013. Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep 3:1140-1152.
68. Milet C, Maczkowiak F, Roche DD, et al. 2013. Pax3 and Zic1 drive induction and differentiation of multipotent, migratory, and functional neural crest in Xenopus embryos. Proc Natl Acad Sci USA 110:5528-5533.
69. Morral JA, Davis AN, Qian J, et al. 2010. Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia. Acta Neuropathol 120:97-108.
70. Moury JD, Jacobson AG. 1990. The origins of neural crest cells in the axolotl. Dev Biol 141:243-253.
71. Murko C, Lagger S, Steiner M, et al. 2013. Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube. Differentiation 85:55-66.
72. Nakagawa S, Takeichi M. 1995. Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 121:1321-1332.
73. Nakamura M, Okano H. 2013. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 23:70-80.
74. Newgreen D, Gibbins I. 1982. Factors controlling the time of onset of the migration of neural crest cells in the fowl embryo. Cell Tissue Res 224:145-160.
75. Nichane M, Ren X, Bellefroid EJ. 2010. Self-regulation of Stat3 activity coordinates cell-cycle progression and neural crest specification. EMBO J 29:55-67.
76. Noisa P, Lund C, Kanduri K, et al. 2014. Notch signaling regulates the differentiation of neural crest from human pluripotent stem cells. J Cell Sci 127:2083-2094.
77. Okamura Y, Saga Y. 2008. Notch signaling is required for the maintenance of enteric neural crest progenitors. Development 135:3555-3565.
78. Olaopa M, Zhou HM, Snider P, et al. 2011. Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation. Dev Biol 356:308-322.
79. Patthey C, Edlund T, Gunhaga L. 2009. Wnt-regulated temporal control of BMP exposure directs the choice between neural plate border and epidermal fate. Development 136:73-83.
80. Pingault V, Bodereau V, Baral V, et al. 2013. Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet 92:707-724.
81. Pingault V, Girard M, Bondurand N, et al. 2002. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum Genet 111:198-206.
82. Plouhinec JL, Roche DD, Pegoraro C, et al. 2014. Pax3 and Zic1 trigger the early neural crest gene regulatory network by the direct activation of multiple key neural crest specifiers. Dev Biol 386:461-472.
83. Pohl BS, Knochel W. 2001. Overexpression of the transcriptional repressor FoxD3 prevents neural crest formation in Xenopus embryos. Mech Dev 103:93-106.
84. Pomp O, Brokhman I, Ben-Dor I, et al. 2005. Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells. Stem Cells 23:923-930.
85. Saadai P, Wang A, Nout YS, et al. 2013. Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele. J Pediatr Surg 48:158-163.
86. Sasai N, Mizuseki K, Sasai Y. 2001. Requirement of FoxD3-class signaling for neural crest determination in Xenopus. Development 128:2525-2536.
87. Sato T, Rocancourt D, Marques L, et al. 2010. A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of myogenesis. PLoS Genet 6:e1000897.
88. Sauka-Spengler T, Bronner-Fraser M. 2008. A gene regulatory network orchestrates neural crest formation. Nature reviews. Mol Cell Biol 9:557-568.
89. Schmucker S, Puccio H. 2010. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches. Hum Mol Genet 19:R103-110.
90. Sechrist J, Serbedzija GN, Scherson T, et al. 1993. Segmental migration of the hindbrain neural crest does not arise from its segmental generation. Development 118:691-703.
91. Selleck MA, Bronner-Fraser M. 1995. Origins of the avian neural crest: the role of neural plate-epidermal interactions. Development 121:525-538.
92. Shah NM, Groves AK, Anderson DJ. 1996. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell 85:331-343.
93. Shi J, Severson C, Yang J, et al. 2011. Snail2 controls mesodermal BMP/Wnt induction of neural crest. Development 138:3135-3145.
94. Sidhoum VF, Chan YM, Lippincott MF, et al. 2014. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab 99:861-870.
95. Soussi-Yanicostas N, de Castro F, Julliard AK, et al. 2002. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 109:217-228.
96. Stewart RA, Arduini BL, Berghmans S, et al. 2006. Zebrafish foxd3 is selectively required for neural crest specification, migration and survival. Dev Biol 292:174-188.
97. Stuhlmiller TJ, Garcia-Castro MI. 2012. FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction. Development 139:289-300.
98. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
99. Tchernev VT, Mansfield TA, Giot L, et al. 2002. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med 8:56-64.
100. Theveneau E, Marchant L, Kuriyama S, et al. 2010. Collective chemotaxis requires contact-dependent cell polarity. Dev Cell 19:39-53.
101. Theveneau E, Mayor R. 2012. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Dev Biol 366:34-54.
102. Trentin A, Glavieux-Pardanaud C, Le Douarin NM, et al. 2004. Self-renewal capacity is a widespread property of various types of neural crest precursor cells. Proc Natl Acad Sci USA 101:4495-4500.
103. Tucker JA, Mintzer KA, Mullins MC. 2008. The BMP signaling gradient patterns dorsoventral tissues in a temporally progressive manner along the anteroposterior axis. Dev Cell 14:108-119.
104. Vallin J, Thuret R, Giacomello E, et al. 2001. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 276:30350-30358.
105. Wei ML. 2006. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 19:19-42.
106. Wu JQ, Habegger L, Noisa P, et al. 2010. Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing. Proc Natl Acad Sci USA 107:5254-5259.
107. Xu W, Wang Y, Liu E, et al. 2013. Human iPSC-derived neural crest stem cells promote tendon repair in a rat patellar tendon window defect model. Tissue Eng Part A 19:2439-2451.
108. Yardley N, Garcia-Castro MI. 2012. FGF signaling transforms non-neural ectoderm into neural crest. Dev Biol 372:166-177.
109. Zhang C, Klymkowsky MW. 2009. Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-kappaB via Nodal and Cerberus. Dev Biol 331:340-349.
110. Zhou H, Wu S, Joo JY, et al. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381-384.